https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
198
 
downloads
18
CITE
How to cite this poster:
Heisen M, Treur MJ, van der Hel WS et al. Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing-remitting multiple sclerosis in the Netherlands. F1000Posters 2012, 3:835 (poster)

Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing-remitting multiple sclerosis in the Netherlands

Marieke Heisen, Maarten J Treur, W Saskia van der Hel1, Martijn T Groot, Bram G Verheggen
Published 25 Jul 2012
Author Affiliations
  • Metrics
  • 198 Views
  • 18 Downloads
Browse by related subjects
Published 25 Jul 2012

Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing-remitting multiple sclerosis in the Netherlands

[version 1; not peer reviewed]

Marieke Heisen, Maarten J Treur, W Saskia van der Hel1, Martijn T Groot, Bram G Verheggen
Author Affiliations
1 Novartis Pharma B.V., The Netherlands
Presented at
22nd Meeting of the European Neurological Society 2012
Abstract
Competing Interests

Corresponding authors WS van der Hel and coauthor MT Groot are paid employees of Novartis Pharma B.V. Coauthors M Heisen, MJ Treur and BG Verheggen are paid employees of Pharmerit B.V., a consulting company which provides services to Novartis Pharma B.V. amongst others.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.